A new treatment that underwent clinical trial for a year has proven to be safe and helped reduce the progress of the disease. Researchers from Purdue University designed a molecule that inhibits the eventual formation of amyloid plaque in the brain, which causes the symptoms of Alzheimer’s. This is developed into a drug which was given to volunteers for clinical trial in 2007. The levels of protein amyloid beta is measured in plasma, and is considered a biomarker. Reduction of this protein indicates the effectiveness of the new drug. A second clinical trial is scheduled this year.
Alzheimer’s disease shows its symptoms usually after the age of 60.
One Response
March 25th, 2009 at 8:36 am
[...] Treatment of presbyopia can be either be the use of eye wear or surgery. There are a lot of choices in using eye wear, the reading glasses, the bifocal or progressive addition lenses (PALs), and the multifocal contact lenses. A new option available for elderly with presbyopia is surgery. [...]